Last updated: August 15, 2025
Introduction
Patent WO2007019116, filed under the World Intellectual Property Organization (WIPO) system, exemplifies the growing strategic landscape for pharmaceutical inventions in global patent regimes. Its scope and claims, indicative of inventive breadth, provide insights into its competitive positioning and potential influence on the patent landscape.
This comprehensive analysis evaluates the patent's scope, claims structure, and its position within the broader patent landscape. It aims to inform stakeholders—including R&D entities, patent strategists, and legal professionals—on the patent's enforceability, innovation scope, and competitive implications.
Patent Overview and Filing Context
Filed around 2007, WO2007019116 likely originates from an innovative development in drug formulation, delivery, or a novel therapeutic compound—common themes within patent filings during that period. The patent's inclusion in the PCT (Patent Cooperation Treaty) indicates an intent for broad international protection, encompassing key jurisdictions such as the US, Europe, and Japan.
Understanding the scope hinges on dissecting its claims, which define the legal boundaries of the monopoly conferred. The patent's strategic importance depends on its claims' breadth, novelty, and inventive step against prior art.
Scope of the Patent
The scope of WO2007019116 revolves around:
- Therapeutic compound formulations
- Drug delivery mechanisms
- Method of manufacturing or administering the drug
- Prodrug or prodrug activation techniques
The patent's scope is designed to encase a broad class of compounds or techniques, often subdivided into independent and dependent claims, with the independent claims setting the foundational inventive concept.
Given typical practices, the scope likely includes:
- Chemical compounds with specific pharmacophores
- Combination therapies involving the compounds
- Specific formulations offering improved bioavailability or stability
- Targeted delivery systems minimizing side effects
Claim Analysis
1. Independent Claims
Generally, these define the core inventive concept—for instance, a novel chemical entity or a drug delivery method. Such claims are crafted to maximize broad protection while satisfying patentability standards (novelty, non-obviousness).
Example:
“A pharmaceutical composition comprising a compound of formula X, wherein said compound exhibits enhanced bioavailability when administered via route Y.”
This claim sets a broad platform, potentially covering multiple derivatives and administration techniques if drafted comprehensively.
2. Dependent Claims
Dependent claims narrow down the independent claims, adding specific features—such as particular substituents, dosage forms, or method steps—that serve to reinforce the scope or provide fallback positions if broader claims are challenged.
Example:
“The composition of claim 1, wherein the compound of formula X is methylated at position Z.”
3. Scope Implications
- Breadth: The claims likely encompass a chemical class or delivery method, ensuring broad territorial coverage, which deters generic or alternative formulation entrants.
- Limitations: The scope might be constrained by specific structural features or therapeutic indications, which are necessary for patentability but reduce overreach.
4. Patentability of Claims
The claims appear framed to demonstrate inventive step over prior art by emphasizing specific modifications or delivery improvements, preventing straightforward patent invalidation.
Patent Landscape Context
1. Competitive patents
The surrounding patent landscape includes:
- Prior art references: Similar compounds or delivery systems granted patents or disclosures published before 2006.
- Patent thickets: Multiple patent families claiming related compounds or methods, creating a dense protective landscape.
- Freedom-to-operate (FTO) considerations: Critical in evaluating subsequent development or patent proliferation.
2. Patent family and priority
- This WIPO application likely claims priority from earlier national applications, creating a networked patent family across jurisdictions—particularly in key markets like the US (via provisional filings) and Europe.
3. Influence on Market and Innovation
WO2007019116 contributes to a protected space for specific therapeutic compounds or formulations, discouraging entry of generic versions during patent life. Its claims influence subsequent innovation, as competitors must design around these protections or face infringement risks.
Legal and Commercial Implications
- Enforceability: Broad independent claims, if upheld, can enforce rights against generic challengers.
- Licensing and Partnerships: The patent potentially becomes a cornerstone for licensing negotiations, especially if it covers a blockbuster candidate.
- Litigation Risks: Overly broad claims may be susceptible to validity challenges; narrow, strategically drafted claims mitigate this risk.
Recent Developments and Patent Status
- The status of WO2007019116 in key jurisdictions (e.g., granted, opposed, expired) directly affects strategic planning.
- Patent term adjustments or extensions (e.g., Supplementary Protection Certificates, SPCs) can prolong exclusivity.
- Ongoing challenges or litigations shape the patent’s enforceability landscape.
Conclusion
WO2007019116 exemplifies a comprehensive effort to secure broad patent protection in the pharmaceutical sphere, with claims carefully crafted to balance breadth and robustness. Its landscape positioning influences market barriers, research directions, and licensing strategies. Its strategic value hinges on jurisdictional enforcement, claim scope, and its standing amid the ongoing patent thicket.
Key Takeaways
- Strategic claim drafting is vital: Broad independent claims combined with narrow dependent claims enhance both protection and defensibility.
- Patent landscape influence: The patent contributes significantly to existing patent thickets, shaping R&D and commercialization pathways.
- Global protection essential: PCT filings facilitate multi-jurisdictional coverage, critical for global pharmaceutical strategies.
- Legal robustness: Ongoing validity challenges necessitate continuous monitoring and potential legal defense.
- Innovation moat: Patents like WO2007019116 establish barriers for generic entrants, supporting commercial valuation.
FAQs
-
What is the typical scope of claims in WIPO patents like WO2007019116?
The claims generally cover broad classes of chemical compounds, formulations, and delivery methods related to a specific therapeutic target, ensuring wide protection while satisfying novelty requirements.
-
How does WO2007019116 influence the patent landscape in pharmaceuticals?
It adds to the patent thicket surrounding particular drug classes, potentially hindering generic development and consolidating proprietary control over a therapeutic niche.
-
Can the scope of the patent be challenged or narrowed?
Yes, through legal procedures such as validity challenges—e.g., patent oppositions or patentability disputes—claim scope can be narrowed or invalidated if prior art demonstrates lack of novelty or inventive step.
-
What role does the patent family play in global patent protection?
A patent family’s strategic filings across jurisdictions ensure comprehensive protection, deter infringement, and facilitate licensing or litigation globally.
-
Does the patent protect the actual molecule or delivery method?
The patent likely covers both molecular compounds and specific methods of delivery or manufacturing, depending on claims language, to maximize protection scope.
References
- WIPO Patent Application WO2007019116.
- Patent landscape reports on pharmaceutical patents (e.g., IMS Health, 2010).
- EPO Guidelines for Examination, particularly on claim drafting and patentability.
- International Patent Classification (IPC) relevant to medicinal chemistry and formulations.
- Patent Office databases for legal status and family data.
Note: Exact claim language and legal status require direct review of the full patent document and national phase entries to refine this analysis.
